The FDA has issued serious 2026 alerts for glucose monitors, including a Class I recall for FreeStyle Libre 3. Learn how to ...
Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.
The FDA has escalated the recall of specific Abbott FreeStyle Libre 3 and 3 Plus CGMs to Class I, the highest level of ...
Abbott recalls glucose sensors linked to 7 deaths and 860 serious injuries; FDA urges discontinuation of specific FreeStyle Libre 3 models.
The U.S. Food and Drug Administration (FDA) is issuing an Early Alert for specific glucose monitoring systems after Abbott ...
The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors ...
Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its transformative Omnipod 5 Automated Insulin ...
This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...
Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...
The Food and Drug Administration (FDA) has now identified the previous recall of certain FreeStyle Libre glucose monitor ...
Medical device maker Abbott Laboratories has reported 860 serious injuries linked to the recall of some of its glucose monitoring sensors, the U.S. Food and Drug Administration said on Wednesday, ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results